Chemically engineered mesoporous silica nanoparticles-based intelligent delivery systems for theranostic applications in multiple cancerous/non-cancerous diseases

In recent years, the unprecedented advances of biomedical nanotechnology have spurred the development of drug delivery systems (DDSs) based on multifarious nanomaterials in disease treatment and diagnostic purposes, which simultaneously boost the therapeutic outcome and circumvent the side effects. Among these, mesoporous silica nanoparticles (MSNs) are acknowledged as one of the most promising candidates for cargo delivery. Their remarkable...